RxDoctor Payments Data

Craig Buckles, MD

Psychiatry · Anderson, INNPI 1487689527

Payments from drug & device makers

$464in general payments, 2019–2025

Across 29 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$85
  • Otsuka America Pharmaceutical, Inc.$84
  • Teva Pharmaceuticals USA, Inc.$65
  • Sunovion Pharmaceuticals Inc.$39
  • Neurocrine Biosciences, Inc.$31
  • Indivior Inc.$30
  • plus $131 from 6 others

What the payments were for

  • Food & beverage$46199%
  • Education$31%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$464 in reported general payments places this provider in the 50th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$59,925
Medicare patients
235
Services billed
665

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate99$294,650
IngrezzaValbenazine Tosylate22$180,423
VraylarCariprazine Hcl72$115,158
FanaptIloperidone34$110,083
AustedoDeutetrabenazine12$96,945
Paliperidone ErPaliperidone212$44,637
Lurasidone Hcl137$40,377
Clozapine387$35,022
Abilify MaintenaAripiprazole12$33,199
TrintellixVortioxetine Hydrobromide31$31,524
Aripiprazole312$31,242
Divalproex Sodium ErDivalproex Sodium201$20,736
NuedextaDextromethorphan Hbr/Quinidine15$19,438
FetzimaLevomilnacipran Hcl21$17,990
Quetiapine Fumarate588$15,541

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$27$294,65099 claims
Neurocrine Biosciences, Inc.Ingrezza$31$180,42322 claims
Vanda Pharmaceuticals Inc.Fanapt$21$110,08334 claims
Teva Pharmaceuticals USA, Inc.Austedo$65$96,94512 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$84$33,19912 claims
Avanir Pharmaceuticals, Inc.Nuedexta$25$19,43815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Anderson

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →